51ÖØ¿ÚÁÔÆæ

The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: ).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Diabetes

Faculty of Medicine / Department of Clinical Sciences, Lund / Section II / Medicine/Emergency Medicine, Lund

Phone: +46 46 222 07 58

Visiting address: Skånes universitetssjukhus, Lund

Postal address: 22184

Description

This project aims to develop incretin therapy as a glucose-reducing strategy in type 2 diabetes (T2D). Its particular focus is to understand the mechanisms of incretin therapy and to optimize its clinical positioning. This mission is achieved by an interdisciplinary approach with complementary studies in subjects with T2D, healthy volunteers and experimental animals.

Staff

A